PATENT CLAIM ANALYSIS

Application Number: 15942802
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-12
Patent Classification: ["514", "230500"]

Abstract:
The present invention is related to Selective Progesterone Receptor Modulators (SPRM) as described and defined herein, and covers the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of sexual hormone dependent diseases and gynaecological diseases in particular Endometriosis or Uterine Fibroids (UF), as a sole agent or in combination with other active ingredients wherein circulating endogenous estradiol concentration of treated women is maintained to a level in a range of 40 pg/mL to 85 pg/mL.

Claim (Index 12):
The Selective Progesterone Receptor Modulator (SPRM) according to  claim 11  wherein the hot flushes are mild- or moderate-hot flush and appear in no more than 25% of the treated women.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 91.0
- Lexical Diversity: 1.33846
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13855559', '12990203', '14440023', '14251192', '12446567']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7945965284804846
- 35 USC 102 Novelty (BERT): 0.532316265231709
- Combined Prediction Score: 0.768368502155607
- Mean Citation Score: 317.07148400000005
- Max Citation Score: 345.38397000000015
- Similarity Product: 189.1089687386656

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test